Article Details
Retrieved on: 2024-05-21 17:01:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FDA grants Breakthrough Therapy Designation to Roche's inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here